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Abstract Plasminogen related growth factors (PRGFs) and
their receptors play major roles in embryogenesis, tissue
regeneration and neoplasia. In order to investigate the complex-
ity and evolution of the PRGF receptor family we have cloned
and sequenced three receptors for PRGFs in the teleost fish Fugu
rubripes, a model vertebrate with a compact genome. One of the
receptor genes isolated encodes the orthologue of mammalian
MET, whilst the other two may represent Fugu rubripes
orthologues of RON and SEA. This is the first time three
PRGF receptors have been identified in a single species.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Plasminogen related growth factors (PRGFs) are a family
of high molecular weight proteins with a mechanism of pro-
teolytic activation that resembles that of the serine proteinase
precursor plasminogen [1]. They play important roles in em-
bryogenesis [2^4], tissue regeneration [5,6] and neoplasia [7].
In mammals, two plasminogen related growth factors, HGF/
SF [8] (hepatocyte growth factor/scatter factor) and HGFl/
MSP [9] (hepatocyte growth factor-like/macrophage stimulat-
ing protein), have been identi¢ed that act on target cells
through receptor tyrosine kinases known as MET [10] and
RON [11] respectively. Recently a receptor of the MET/
RON family was identi¢ed in chicken as the cellular homo-
logue of the v-SEA oncogene [12]. SEA does not appear to be
the avian orthologue of human RON because it is not acti-
vated by either human or chicken HGFl/MSP. These data
suggest the presence of a third ligand receptor system within
the PRGF and PRGF receptor (PRGFR) families although
attempts at cloning the avian orthologue of RON or the
mammalian orthologue of SEA have been unsuccessful. In
order to investigate the complexity and evolution of the
PRGF receptor family we have cloned and sequenced three
receptors for PRGFs in the teleost ¢sh Fugu rubripes, a model
vertebrate with a compact genome [13].
2. Materials and methods
2.1. Cloning of PRGF receptors in Fugu rubripes
From an alignment of PRGF receptor sequences (available in
EMBL [14]) from a number of vertebrates, degenerate primers were
designed within the tyrosine kinase domain to amplify coding and
intron sequence from Fugu rubripes genomic DNA: A, forward pri-
mer: 5P ctg gcn gcn mgg aay tgy atg (translation LAARNCM);
B, reverse primer: 5P gac can acr tcn gay ttn gtn gtn gtr aa 3P (trans-
lation FTTKSDVW).
The PCR products generated were sub-cloned into EcoRV cut
pBluescript (Stratagene) and sequenced using KS primer and Amer-
sham Thermo Sequenase dye terminator reactions. The sequences
generated were then used in BLAST v2.0 [15] searches of the Swiss-
Prot, TREMBL [16] and EMBL databases. Speci¢c primers were then
generated to positive clones: 1, forward tk83F: 5P gtc acg gac atg tgg
gga gc 3P ; reverse tk83R: 5P gac tcg tcc agc ctg aac cc 3P ; 2, forward
tk102F: 5P gtt cat cta cgt gag ttc ggt g 3P ; reverse tk102R: 5P gct ctc
atc cag cct gtc gg 3P ; 3, forward tk332F: 5P gtg aca ccc tga gac gacg
3P ; reverse tk332R: 5P gta cgt ttc atc cac cct ggg 3P.
2.2. Isolation and sequencing of Fugu rubripes genomic clones
containing PRGF receptors
The speci¢c primers were used to generate three PCR products
from Fugu rubripes genomic DNA, these were used to probe a Fugu
rubripes unampli¢ed phage lambda library and an unampli¢ed cosmid
high density gridded library (MRC HGMP Resource Centre UK).
Positive clones were Southern blotted and overlapping clones deter-
mined. Selected clones were then sequence scanned (see Fugu rubripes
landmark mapping web page for details http://fugu.hgmp.mrc.ac.uk).
2.3. Characterisation of PRGF receptors and neighbouring genes
Sequences were transferred to a UNIX environment and clipped
using a modi¢ed Pregap [17] script. Sequences were screened against
sequencing (pBluescript and M13) and cosmid (Lawrist4) vectors
and matching regions were masked. Passed sequences were then as-
sembled using Gap4 [18] and Pint (P. Weston, unpublished data,
http://menu.hgmp.mrc.ac.uk/cgi-bin/pint.pl). Areas of discrepancy,
those not covered by a clone and single stranded regions were
veri¢ed by PCR and sequenced or veri¢ed by primer walking.
Analyses of the ¢nished sequences were carried out using Nix
(G. Williams, P. Woollard and P. Hingamp, unpublished data,
http://menu.hgmp.mrc.ac.uk/menu-bin/Nix.pl) and ClustalW [19], for
the PRGF receptors this was veri¢ed by sequencing RT-PCR prod-
ucts. Phylogenetic analysis was undertaken using SEAVIEW and
PHYLO_WIN [20].
3. Results and discussion
PRGF receptor fragments have been isolated by degenerate
PCR and the full genomic sequences elucidated from cosmid
clones selected by hybridisation with the PCR products. We
have designated the three PRGF receptor genes PRGFR1,
PRGFR2 and PRGFR3. The PRGFR1 gene spans at least
36 790 nucleotides on two overlapping cosmids (Fig. 1). It is
£anked by Fugu rubripes homologues of mammalian caveolin
1 and 2 genes which have recently been mapped to chromo-
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somes 6-A2 in mouse and 7q31 in man [21], the same chro-
mosomal location as the MET gene. The PRGFR2 gene spans
at least 7589 nucleotides on cosmid 168J21 (Fig. 1). It is
£anked at the 3P end by a gene homologous to a rat calmod-
ulin binding protein and at the 5P end on the complemen-
tary strand, by a gene homologous to ubiquitin activating
enzyme E1 (UBE1). The latter gene maps to chromosome
Xp11 in man but its paralogue maps to 3p21 [22], the same
chromosomal location as the RON gene. Cosmid 122L06 (se-
quence available from http://fugu.hgmp.mrc.ac.uk) overlaps
168J21 at the 5P end and contains sequences with homology
to the human cosmid LUCA15 (EMBL accession number:
U73166) which maps to 3p21 and to the G protein GNAI2
[23] which also maps to 3p21 in man. The PRGFR3 gene
spans at least 9541 nucleotides in cosmid 165K09 and is
£anked at the 5P end by three genes. One has similarity only
to Caenorhabditis elegans (EMBL accession number: U61954)
and yeast genes (EMBL accession numbers: X94106 and
Z69239). A second gene shows highest homology to the me-
tabotropic glutamate receptor 7 (GRM7) [24] which we have
mapped to chromosome 3 in man (unpublished data). The
third gene, present on the complementary strand, appears to
be the Fugu rubripes orthologue of the TRAF interacting pro-
tein (TRIP) [25]. Human TRIP has recently been mapped to
3p21 (Fig. 1). Although the Fugu rubripes loci for PRGFR2
and PRGFR3 both contain genes with human homologues
mapping to 3p21, we do not know whether they are linked
in the Fugu rubripes genome.
The intron-exon structure of the PRGFR1, PRGFR2 and
PRGFR3 genes is described in Table 1. Despite the greater
length of the PRGFR1 gene, all three genes have a similar
structure with 20 coding exons and 19 introns. This re£ects
the organisation of human MET [26] and mouse ron [27]
which are the only members of this family to have been char-
acterised so far at the genomic level. The intron phases of the
corresponding exons are identical in the ¢ve genes, although
intron sizes are signi¢cantly larger in PRGFR1 and human
MET ; PRGFR1 and human MET span V37 kb and V130
kb respectively compared with 7.6 kb for PRGFR2, 9.5 kb for
PRGFR3 and 13.2 kb for mouse ron (Table 1). These data
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Fig. 1. Schematic organisation of Fugu rubripes PRGFR1, PRGFR2
and PRGFR3 loci. Arrangement of genes is shown to scale along
the genomic locus as a series of open or shaded boxes. Open boxes
represent genes neighbouring PRGFRs, ¢lled boxes represent the
PRGFRs, those below the locus bar are on the complementary
strand. For brevity, only the canonical tiling path for genomic cos-
mid clones is shown below the locus bar. Each genomic region is
represented with multiple independent genomic clones (not shown).
CAV and CAV2 represent the Fugu rubripes homologues of human
caveolin (EMBL accession number: Z18951) and caveolin-2 (EMBL
accession number: AF035752). UBE1 represents the Fugu rubripes
homologue of human ubiquitin activating enzyme E1 or E1-like
(EMBL accession number: X56976); the 3P end of the UBE1 gene
is not present on cosmid 168J21 as indicated by the arrow. The
calmodulin binding protein gene represents the Fugu rubripes homo-
logue of a Rattus norvegicus calmodulin binding protein (EMBL ac-
cession number: L22557). GRM7 represents the Fugu rubripes ho-
mologue of human metabotropic glutamate receptor 7 (EMBL
accession number: X94552); the 5P end of the GRM7 gene is not
present on cosmid 165K09 as indicated by the arrow. TRIP repre-
sents the Fugu rubripes orthologue of human TRIP (TRAF (tumor
necrosis factor receptor associated factor) interacting protein)
(EMBL accession number: U77845). Sand is a novel gene with ho-
mology to predicted proteins in Saccharomyces cerevisiae (EMBL
accession number: X94106), Schizosaccharomyces pombe (EMBL ac-
cession number: Z69239) and Caenorhabditis elegans (EMBL acces-
sion number: U61954).
Table 1

















1 1200 1206 1221 A 1316 1405 15 215 0
2 177 177 204 B 319 74 1 887 0
3 120 123 129 C 125 482 85 0
4 171 171 174 D 76 529 415 0
5 164 161 158 E 112 365 673 II
6 133 136 115 F 75 73 95 0
7 137 137 137 G 104 269 100 II
8 180 180 165 H 88 81 211 II
9 100 100 100 I 76 250 4 518 0
10 228 219 210 J 89 87 2 433 0
11 147 147 150 K 75 150 1 616 0
12 163 154 154 L 68 154 373 I
13 90 90 135 M 154 95 817 I
14 210 216 261 N 87 223 1 393 I
15 81 81 81 O 83 91 1 073 I
16 182 182 182 P 72 134 153 0
17 110 110 110 Q 332 83 102 II
18 166 166 166 R 73 117 118 0
19 137 137 137 S 141 757 1 234 II
20 229 229 286 ^ ^ ^ ^ ^
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further strengthen the conclusion that PRGFR1 encodes Fugu
rubripes MET and emphasise that the PRGF receptors of the
RON/SEA subfamily have a compact gene structure com-
pared to that of MET.
The protein sequences encoded by the PRGFR1, PRGFR2
and PRGFR3 genes are shown in Fig. 2 and aligned with the
other known sequences of PRGF receptors. The alignment
highlights the conserved features of this family of receptor
tyrosine kinases, namely an open reading frame in the region
of 1400 amino acids and a furin cleavage site (Fig. 2) located
on average 300 residues from the translation start site. Pro-
cessing of the furin site during receptor secretion and trans-
location results in the typical heterodimeric (K/L) structure of
the PRGF receptors, with an K-chain of 275^291 residues
located outside the membrane disulphide-linked to the larger
L-chain. The L-chain comprises a large extracellular domain
of 627^665 residues, a single trans-membrane domain of 27^
29 residues (Fig. 2), a linker of 69^123 residues which joins
the trans-membrane and the kinase domains, a typical cyto-
plasmic kinase domain of 259^260 residues (Fig. 2) and a C-
terminal peptide containing the two tyrosine residues (Fig. 2)
essential for downstream signalling of both the MET and
RON receptors. These features are present in all known
PRGF receptors [28,29] (Fig. 2). Notable are two conserved
sequences in all PRGFRs (Fig. 3), in the extra-membrane
domain of the L-chain (Fig. 2): the ¢rst is 81 residues in
length and is cysteine-rich; the second is 45 residues in length
and is rich in glycine, proline and hydrophobic residues. Both
sequences may be important for the three-dimensional struc-
ture of the extra-membrane domain of the L chain.
The predicted coding sequences of the PRGFR1, PRGFR2
and PRGFR3 genes indicate that all three encode potentially
functional proteins. The three genes were investigated by RT-
PCR and sequence data from the PCR products con¢rmed
expression. PRGFR1 is expressed predominantly in the liver,
gonads, kidney, gill and ovaries, PRGFR2 is expressed in all
tissues examined and PRGFR3 is expressed in the gonads,
kidney and gill.
The amino acid sequences of the PRGFR1, PRGFR2 and
PRGFR3 genes are signi¢cantly diverged as indicated by se-
quence similarities of only 36% between PRGFR1 and
PRGFR2, 32% between PRGFR1 and PRGFR3 and 58% be-
tween PRGFR2 and PRGFR3. Whilst the PRGFR1 gene
shows higher levels of sequence identity with the MET recep-
tors (50%) than with the RON/SEA receptors (35%), the op-
posite is true for the PRGFR2 and PRGFR3 genes which
show levels of sequence identity with the MET receptors
(39%) and levels of sequence identity with the RON/SEA
(44%). The PRGFR2 and PRGFR3 genes show similar levels
of sequence identity with the RON receptors (40%) but the
PRGFR3 gene shows the greatest level of sequence identity
with the SEA receptors (46%). On this basis and incorporat-
ing linkage data (Fig. 1), we can identify the PRGFR1 gene as
the orthologue of the MET gene. It is di⁄cult to predict
whether PRGFR2 and PRGFR3 are the orthologues of
RON and SEA respectively as linkage data place both at
3p21 in man, the locus of the RON receptor gene. There
are no mapping data for SEA in any vertebrate. Phylogenetic
analysis (Fig. 3) is complicated by the fact that comparisons
to PRGFR2 are being made with mammalian genes and com-
parisons to PRGFR3 are being made with chicken and Xen-
opus genes. In fact it appears that PRGFR2 and PRGFR3 are
most similar to each other and may have arisen by a dupli-
FEBS 21488 1-2-99 Cyaan Magenta Geel Zwart
Fig. 3. Phylogeny of the plasminogen related growth factor receptor
amino acid sequences. The sequences used were as in Fig. 2, but in-
clude the human insulin growth factor receptor Hs_InsR (SwissProt
accesion number: P06213). The tree was constructed using PHY-
LO_WIN [20] selecting the neighbour joining method and using
Hs_InsR as an outgroup. As is clearly indicated the PRGF recep-
tors can be clustered into two subfamilies: the MET subfamily and
the RON/SEA subfamily. Only Fugu rubripes has two members of
the RON/SEA subfamily characterised to date, thus in this analysis
the relationship between these subfamily members is unclear and
may be more representative of relationships between vertebrates.
A: Divergence of common ancestral gene for SEA, RON, PRGFR2
and PRGFR3. B: Divergence of SEA and RON. C: Divergence of
PRGFR2 and PRGFR3. Numbers on the nodes indicate percentage
recovery of these nodes per 500 bootstrap replications.
Fig. 2. Protein alignment and domain boundaries of the plasmino-
gen related growth factor receptors. The sequences used: Hs_Met
(SwissProt accession number: P08581), Hs-Ron (SwissProt accession
number: Q04912), Mm-Met (SwissProt accession number: Q62125),
Mm_Ron (SwissProt accession number: G2231241)*, Rn_Met
(TREMBL accession number: P97579), X1_Sea (SwissProt accession
number: G1679600)**, Xl_Met (OWL accession number: JC5148),
Gg_Met (TREMBL accession number: Q90975), Gg_Sea (TREMBL
accession number: Q08757), PRGFR1, PRGFR2 and PRGFR3.
The alignment was produced using CUSTALW [19]. Cysteines in
the extra-membrane domain are shown on a cyan background. The
signal peptide is shown in magenta. The furin cleavage site is shown
in green. The single trans-membrane domain is shown in blue. The
typical cytoplasmic kinase domain is shown in red. Shown on yel-
low background are two tyrosine residues in the C-terminal peptide
essential for downstream signalling. These features are present in all
known PRGF receptors. Shown underlined are two conserved se-
quences present in the extra-membrane domain of the L-chain: the
¢rst is 81 residues in length and is cysteine-rich; the second is 45
residues in length and is rich in glycine, proline and hydrophobic
residues. Both sequences may be important for the three-dimension-
al structure of the extra-membrane domain of the L-chain.
* X1_Sea: designated RON in EMBL and SEA in SwissProt.
** Mm_Ron: an exon is missing after exon 12 from the submitted
protein sequence.
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cation event that post dates the divergence of the SEA and
RON genes (Fig. 3, node C). However, the common ancestor
of the PRGFR2 and PRGFR3 genes (Fig. 3, node A) predates
the divergence of the RON and SEA genes (Fig. 3, node B). It
would appear that this common ancestor has been duplicated
in at least one other vertebrate as neither human nor chicken
HGFl/MSP activates chicken SEA, therefore a third PRGF/
receptor system which is of the Sea/Ron lineage would seem
to be operating in chicken as well as Fugu rubripes.
The data presented here clearly indicate that the PRGF
receptors can be clustered into two subfamilies : the MET
subfamily including PRGFR1 and the RON/SEA subfamily
which includes both PRGFR2 and PRGFR3. The two sub-
families can be recognised through pair-wise sequence com-
parisons, the length of the extra-membrane domain of the L-
chain (on average 629 residues in the MET subfamily and 649
residues in the RON/SEA subfamily) and the length of the
linker between the trans-membrane and the kinase domains
(on average 116 residues in the MET subfamily and 89 resi-
dues in the RON/SEA subfamily) (Fig. 2). Several sequence
signatures in the K-chain, in the extra-cellular domain of the
L-chain and in the linker between the trans-membrane and the
kinase domains further discriminate PRGF receptors of the
MET and RON/SEA subfamilies (Fig. 2). Phylogenetic anal-
ysis of the PRGF receptors, using the sequence of the human
insulin receptor as an outgroup, con¢rms that the two sub-
families form distinct clusters (Fig. 3).
We have utilised sequence, domain and phylogenetic anal-
ysis to investigate three Fugu rubripes PRGFR genes. We have
shown conservation of the intron-exon structure of the PRGF
receptor genes across vertebrates and have provided the basis
for classifying the PRGF receptor genes into two subfamilies.
Signi¢cantly we have shown, for the ¢rst time, direct evidence
that a single species expresses three PRGF receptors, support-
ing receptor/ligand data from chicken and man implying that
other species, including mammals, may express a third recep-
tor and corresponding ligand. Receptor/ligand binding studies
of the Fugu rubripes genes should con¢rm their function and
will clearly be required in order to reconstruct the roles of
PRGFs and their receptors in vertebrate species.
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